In Vivo PET Brain Imaging of the Type 1 Cannabinoid Receptor in Early and Advanced Parkinson's Disease

被引：0
|
作者：
Van Laere, K. [1 ]
Casteels, C. [1 ]
Lunskens, S. [1 ]
Goffin, K. [1 ]
Gerard, N. [1 ]
Bormans, G. [2 ]
Grachev, I. [3 ]
Vandenberghe, W. [1 ]
机构：
[1] Univ Hosp Leuven, Louvain, Belgium
[2] Katholieke Univ Leuven, Louvain, Belgium
[3] Merck Imaging, West Point, PA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [21] CB1 cannabinoid receptor signalling in Parkinson's disease
    Brotchie, JM
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) : 54 - 61
  • [22] Research progress on the cannabinoid type-2 receptor and Parkinson's disease
    Yu, Xiaoqi
    Jia, Yi
    Dong, Yuan
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 15
  • [23] Decreased Cannabinoid Type 1 Receptor Density in Parkinson's Disease: A [18F]FMPEP-d2 PET Study
    Bruck, A.
    Al-Abdulrasul, H.
    Tuisku, J.
    Ajalin, R.
    Hirvonen, J.
    Rinne, J.
    MOVEMENT DISORDERS, 2019, 34 : S773 - S773
  • [24] PET functional imaging of deep brain stimulation in Parkinson's disease
    Thobois, Stephane
    Broussolle, Emmanuel
    JOURNAL OF NEUROLINGUISTICS, 2012, 25 (02) : 133 - 138
  • [25] PET Imaging in Parkinson's disease
    Dhawan, Vijay
    Eidelberg, David
    CURRENT MEDICAL IMAGING, 2007, 3 (04) : 233 - 241
  • [26] Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease
    Casteels, C.
    Vandeputte, C.
    Rangarajan, J. R.
    Dresselaers, T.
    Riess, O.
    Bormans, G.
    Maes, F.
    Himmelreich, U.
    Nguyen, H.
    Van Laere, K.
    EXPERIMENTAL NEUROLOGY, 2011, 229 (02) : 440 - 449
  • [27] Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
    Rawaha Ahmad
    Andrey Postnov
    Guy Bormans
    Jan Versijpt
    Mathieu Vandenbulcke
    Koen Van Laere
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2219 - 2227
  • [28] Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
    Ahmad, Rawaha
    Postnov, Andrey
    Bormans, Guy
    Versijpt, Jan
    Vandenbulcke, Mathieu
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2219 - 2227
  • [29] Metabolic and type 1 cannabinoid receptor mapping in early transgenic rats of Huntington's disease
    Casteels, C.
    Vandeputte, C.
    Dresselaers, T.
    Nguyen, H.
    Bormans, G.
    Riess, O.
    Himmelreich, U.
    Van Laere, K.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [30] Radiosynthesis and evaluation of new PET ligands for peripheral cannabinoid receptor type 1 imaging
    Yamasaki, Tomoteru
    Fujinaga, Masayuki
    Shimoda, Yoko
    Mori, Wakana
    Zhang, Yiding
    Wakizaka, Hidekatsu
    Ogawa, Masanao
    Zhang, Ming-Rong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (17) : 4114 - 4117
12345